Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells

Murali Subramani, Murugeswari Ponnalagu, Lekshmi Krishna, Nallathambi Jeyabalan, Priyanka Chevour, Anupam Sharma, Chaitra Jayadev, Rohit Shetty, Nargis Begum, Govindaraju Archunan, Debashish Das*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number12242
Number of pages16
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - 25 Sep 2017

Keywords

  • PIGMENT EPITHELIAL-CELLS
  • DIABETIC MACULAR EDEMA
  • TO-MESENCHYMAL TRANSITION
  • GROWTH-FACTOR PHARMACOTHERAPY
  • ACTIVATED POTASSIUM CHANNELS
  • DIFFERENT OCULAR CELLS
  • ANTI-VEGF THERAPY
  • CHOROIDAL NEOVASCULARIZATION
  • MEDIATED INHIBITION
  • OXIDATIVE STRESS

Cite this